5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

By F. Cardoso, S. Paluch-Shimon, E. Senkus, G. Curigliano, M. Aapro, F. André, C. Barrios, J. Bergh, G. Bhattacharyya, L. Biganzoli and 35 more. Annals of Oncology, 2020

1,189 citations recorded by the source corpus.

F. Cardoso, S. Paluch-Shimon, E. Senkus, G. Curigliano, M. S. Aapro, F. André, C. H. Barrios, J. Bergh, G. S. Bhattacharyya, L. Biganzoli, F. Boyle, M.-J. Cardoso, L. A. Carey, J. Cortés, N. S. El Saghir, M. Elzayat, A. Eniu, L. Fallowfield, P. A. Francis, K. Gelmon, J. Gligorov, R. Haidinger, N. Harbeck, X. Hu, B. Kaufman, R. Kaur, B. E. Kiely, S.-B. Kim, N. U. Lin, S. A. Mertz, S. Neciosup, B. V. Offersen, S. Ohno, O. Pagani, A. Prat, F. Penault-Llorca, H. S. Rugo, G. W. Sledge, C. Thomssen, D. A. Vorobiof, T. Wiseman, B. Xu, L. Norton, A. Costa & E. P. Winer Breast Unit, Champalimaud Clinical Centre/Champalimaud Foundation, Lisbon, Portugal; Sharett Division of Oncology, Hadassah University Hospital, Jerusalem, Israel; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland; Department of Oncology and Hemato-Oncology, European Institute of Oncology, IRCCS, Division of Early Drug Development, University of Milan, Milan, Italy; Breast Center, Clinique de Genolier, Genolier, Switzerland; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France; Latin American Cooperative Oncology Group (LACOG), Grupo Oncoclínicas, Porto Alegre, Brazil; Department of Oncology-Pathology, Karolinska Institute & University Hospital, Stockholm, Sweden; Department of Medical Oncology, Salt Lake City Medical Centre, Kolkata, India; Department of Medical Oncology, Nuovo Ospedale di Prato e Istituto Toscano Tumori, Prato, Italy; The Pam McLean Centre, Royal North Shore Hospital, St Leonards, Australia; Nova Medical School, Lisbon, Portugal; Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA; IOB Institute of Oncology, Quiron Group, Madrid & Barcelona; Department of Oncology, Vall d’Hebron Institute of Oncology, Barcelona, Spain; Division of Hematology Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Europa Donna, The European Breast Cancer Coalition, Milan, Italy; Interdisciplinary Oncology Service (SIC), Riviera-Chablais Hospital, Rennaz, Switzerland; SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton, UK; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Medical Oncology Department, BC Cancer Agency, Vancouver, Canada; Breast Cancer Expert Center, University Cancer Institute APHP, Sorbonne University, Paris, France; Brustkrebs Deutschland e.V., Munich, Germany; Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel; Breast Cancer Welfare Association Malaysia, Petaling Jaya, Malaysia; NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, Australia; Department of Oncology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea; Susan Smith Center for Women’s Cancers e Breast Oncology Center, Dana-Farber Cancer Institute, Boston, USA; Metastatic Breast Cancer Network, Inverness, USA; Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, Peru; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark; Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan; Medical School, Geneva University Hospital, Geneva, Switzerland; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona; Department of Medicine, University of Barcelona, Barcelona, Spain; Department of Biopathology, Centre Jean Perrin, Clermont-Ferrand; University Clermont Auvergne/INSERM U1240, Clermont-Ferrand, France; Breast Oncology Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA; Division of Oncology, Stanford School of Medicine, Stanford, USA; Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany; Oncology Research Unit, Belong.Life, Tel Aviv, Israel; Department of Applied Health Research in Cancer Care, The Royal Marsden Hospital NHS Foundation Trust, London, UK; Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China; Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA; European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland

Subfields: Cancer Research, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/0b0091c86b4b12737807f082e7459e7734f8a391

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. S. Loibl
  2. A. Gennari
  3. S. Paluch-Shimon
  4. N. Turner
  5. F. André
  6. Mark E. Robson
  7. G. Curigliano
  8. C. Barrios

Citations in the corpus